We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $272M
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$209M
AUM Growth
-$111K
Cap. Flow
-$4.23M
Cap. Flow %
-2.03%
Top 10 Hldgs %
77.78%
Holding
58
New
2
Increased
2
Reduced
27
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$593K
2
ILMN icon
Illumina
ILMN
+$273K
3
WU icon
Western Union
WU
+$216K
4
INTU icon
Intuit
INTU
+$550

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.94M
2
CELG
Celgene Corp
CELG
+$670K
3
ADBE icon
Adobe
ADBE
+$505K
4
AAPL icon
Apple
AAPL
+$450K
5
CSCO icon
Cisco
CSCO
+$254K

Sector Composition

Rank Sector Weight
1 Healthcare 40.73%
2 Technology 36.19%
3 Communication Services 9.27%
4 Consumer Discretionary 4%
5 Industrials 3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$41.3M 19.79%
415,615
-7,050
-2% -$670K
ADBE icon
2
Adobe
ADBE
$89.5B
$26.6M 12.78%
96,465
-1,730
-2% -$505K
IDXX icon
3
Idexx Laboratories
IDXX
$42.9B
$24.8M 11.89%
91,182
-6,955
-7% -$1.94M
MSFT icon
4
Microsoft
MSFT
$2.84T
$16.5M 7.92%
118,734
-300
-0.3% -$41.3K
AAPL icon
5
Apple
AAPL
$4.89T
$11.5M 5.54%
206,232
-8,608
-4% -$450K
ISRG icon
6
Intuitive Surgical
ISRG
$121B
$9.23M 4.43%
51,309
-660
-1% -$114K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$3.9T
$8.61M 4.13%
141,240
-1,320
-0.9% -$78.1K
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$3.91T
$8.01M 3.84%
131,120
-1,000
-0.8% -$59.2K
CSCO icon
9
Cisco
CSCO
$450B
$7.92M 3.8%
160,346
-4,885
-3% -$254K
PAYX icon
10
Paychex
PAYX
$40.4B
$7.64M 3.66%
92,295
-2,150
-2% -$179K
BKNG icon
11
Booking.com
BKNG
$138B
$4.22M 2.02%
53,750
– –
AMZN icon
12
Amazon
AMZN
$2.5T
$3.39M 1.63%
39,100
– –
QCOM icon
13
Qualcomm
QCOM
$176B
$3.29M 1.58%
43,203
-2,500
-5% -$188K
UPS icon
14
United Parcel Service
UPS
$97.6B
$3.29M 1.58%
27,494
-250
-0.9% -$28.6K
TROW icon
15
T. Rowe Price
TROW
$25B
$2.28M 1.09%
19,960
-40
-0.2% -$4.45K
PACB icon
16
Pacific Biosciences
PACB
$422M
$2.28M 1.09%
441,650
+106,000
+32% +$593K
JNJ icon
17
Johnson & Johnson
JNJ
$635B
$2.15M 1.03%
16,651
-50
-0.3% -$6.59K
NTR icon
18
Nutrien
NTR
$32.7B
$1.94M 0.93%
38,792
-360
-0.9% -$18.4K
ENB icon
19
Enbridge
ENB
$124B
$1.9M 0.91%
54,222
-1,595
-3% -$55.2K
T icon
20
AT&T
T
$165B
$1.8M 0.86%
62,979
– –
PWR icon
21
Quanta Services
PWR
$93.9B
$1.73M 0.83%
45,750
-1,400
-3% -$50.6K
TMP icon
22
Tompkins Financial
TMP
$1.45B
$1.68M 0.8%
20,650
– –
PFE icon
23
Pfizer
PFE
$140B
$1.12M 0.54%
32,842
-527
-2% -$19.2K
V icon
24
Visa
V
$677B
$1.12M 0.54%
6,500
-1,200
-16% -$214K
AMGN icon
25
Amgen
AMGN
$203B
$946K 0.45%
4,887
– –
1
2 3

Similar funds

SC
Swan Capital Pensacola, Florida $272M AUM 14.84% 1-Year Est. Return
SC
Seldon Capital San Francisco, California $272M AUM 90.68% 1-Year Est. Return
AGP
Autumn Glory Partners Dallas, Texas $272M AUM 20.37% 1-Year Est. Return
SFPG
Stonebridge Financial Planning Group Orlando, Florida $272M AUM 16.91% 1-Year Est. Return
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
SS
Spinecap SAS Paris, France $272M AUM 23.45% 1-Year Est. Return
LAM
Lountzis Asset Management Wyomissing, Pennsylvania $273M AUM 19.71% 1-Year Est. Return

Bourne Lent Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Bourne Lent Asset Management held 58 positions worth $209M, down 0.05% from $209M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bourne Lent Asset Management's Q3 2019 filing shows 2 new, 2 increased, 27 reduced and 1 closed positions. Its largest new stake was Illumina: 925 shares worth $274K. The largest sale was Idexx Laboratories, an estimated $1.94M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 41% a quarter earlier, followed by Technology and Communication Services.

  • Bourne Lent Asset Management's largest Q3 2019 buy was Illumina: 925 shares worth $274K.
  • Bourne Lent Asset Management added most to Pacific Biosciences in Q3 2019, an estimated $593K increase.
  • Bourne Lent Asset Management's biggest Q3 2019 reduction was Idexx Laboratories, cutting an estimated $1.94M.
  • Bourne Lent Asset Management fully exited Rio Tinto in Q3 2019, selling an estimated $212K.
  • Bourne Lent Asset Management's ten largest holdings make up 78% of its $209M portfolio in Q3 2019.
  • Bourne Lent Asset Management opened 2 new positions and closed 1 in Q3 2019.
  • Bourne Lent Asset Management's portfolio value fell 0.05% quarter-over-quarter to $209M.

Based on Bourne Lent Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.